- Contrary to a Financial Times report, GlaxoSmithKline (GSK -0.8%) says that it has no plans to spin off its consumer healthcare division according to Bloomberg.
- It is proceeding with a JV with Novartis (NVS -0.8%) to create a consumer health company with ~6.5B pounds ($11B) in annual revenue. The transaction won't close until next year, though.